Drug Houses of Australia (DHA) was originally established in 1936[1] as an amalgamation of seven Australian pharmaceutical companies, notably A. M. Bickford & Sons.
[1] Drug Houses of Australia is now a leading generic pharmaceutics and Chinese proprietary medicine (CPM) manufacturer based in Jurong, Singapore.
It was sold to Strides Arcolab through a share purchase agreement with Haw Par Healthcare Limited, Singapore in September 2006 for approximately SGD$19.7 million.
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub.
You can help Wikipedia by expanding it.This article about an Australian corporation or company is a stub.